Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Inovio Pharmaceuticals Inc (NASDAQ: INO) closed the day trading at $1.95 up 2.63% from the previous closing price of $1.90. In other words, the price has increased by $2.63 from its previous closing price. On the day, 0.56 million shares were traded. INO stock price reached its highest trading level at $2.02 during the session, while it also had its lowest trading level at $1.89.
Ratios:
For a better understanding of INO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.63 and its Current Ratio is at 2.63. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on May 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.
On January 25, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 71515080 and an Enterprise Value of 14423563. For the stock, the TTM Price-to-Sale (P/S) ratio is 255.43 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 50.949 whereas that against EBITDA is -0.138.
Stock Price History:
The Beta on a monthly basis for INO is 1.31, which has changed by -0.7583643 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, INO has reached a high of $12.33, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 1.18%, while the 200-Day Moving Average is calculated to be -39.23%.
Shares Statistics:
Over the past 3-months, INO traded about 667.11K shares per day on average, while over the past 10 days, INO traded about 718360 shares per day. A total of 36.67M shares are outstanding, with a floating share count of 36.39M. Insiders hold about 0.79% of the company’s shares, while institutions hold 37.18% stake in the company. Shares short for INO as of 1748563200 were 6567916 with a Short Ratio of 9.85, compared to 1745971200 on 6464542. Therefore, it implies a Short% of Shares Outstanding of 6567916 and a Short% of Float of 18.030001000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Inovio Pharmaceuticals Inc (INO) is currently under the scrutiny of 4.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.61, with high estimates of -$0.56 and low estimates of -$0.72.
Analysts are recommending an EPS of between -$2.08 and -$2.71 for the fiscal current year, implying an average EPS of -$2.34. EPS for the following year is -$2.11, with 4.0 analysts recommending between -$1.47 and -$2.86.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for INO’s current fiscal year. The highest revenue estimate was $215k, while the lowest revenue estimate was $65k, resulting in an average revenue estimate of $109k. In the same quarter a year ago, actual revenue was $217.76kBased on 5 analysts’ estimates, the company’s revenue will be $16.36M in the next fiscal year. The high estimate is $41.52M and the low estimate is $900k.
